Episode Details

In the latest Trade To Black podcast, host Shadd Dales and Anthony Varrell dive into the latest cannabis news coming out of Washington.Despite supporting cannabis rescheduling and banking reform on the campaign trail, the Trump administration now says it has “no action” planned for marijuana policy—at least for now. Meanwhile, Florida’s legalization campaign faces legal heat over alleged election law violations.On the psychedelic front, Shadd and Anthony welcome in MindMed CEO Robert Barrow. With Phase 3 trials underway for MM120, targeting Generalized Anxiety Disorder, MindMed is positioning itself as a leader in the future of mental health treatment, including LSD-based therapies.They also break down the ripple effects of RFK Jr.’s appointment to HHS and the FDA’s recent rejection of MDMA therapy—issues that could shape the regulatory landscape under the Trump administration.Log on to learn on cannabis stocks, marijuana reform, and the 2025 outlook for the psychedelic industry. #CannabisNews #TrumpAdministration #CannabisStocks #PsychedelicStocks #MindMed #LSD #MarijuanaRescheduling #MentalHealth #MM120 #Election2026 #CannabisIndustryWant to see last week's recap?   • TDR’s Biggest Developments in Cannabi...  Want to see more Cannabis Reform videos?   • Texas Hemp: Cracking Down On a Big Pr...     • Cannabis Legalization: Why Your Opini...     • DEA Bias Complicates Cannabis Resched...     • How The US Mistakenly Legalized Marij...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:

Listen Now